Skip to content
Citation only via OpenAlex

Oxidative Stress Protection by Novel Telomerase Activators in Mesenchymal Stem Cells Derived from Healthy and Diseased Individuals

Ailon Tichon, Erez Eitan, Basan Gowda Kurkalli, Alex Braiman, Aviv Gazit, Shimon Slavin, E. Beith-Yannai, Elad Priel

Current Molecular Medicine · 2013 · ▲ 28 citations

Abstract

Human Bone Marrow Mesenchymal Stem cells (hMSC) are a promising candidate for cytotherapy. However, the therapeutic potential is limited since the therapy requires ex-vivo cell culturing in which deterioration in cellular viability and aging is observed with time.Telomerase ribonucleoprotein complex re-elongates telomeres and therefore promotes genomic integrity, proliferation and lifespan. Recently we showed that increasing telomerase reverse transcriptase (TERT) expression by novel compound confers resistance from apoptosis induced by oxidative stress. Here we investigated the possibility that a controlled induction of human TERT (hTERT) levels by chemical compounds (AGS-499 and AGS-500) might improve the functionality of hMSC derived from healthy and neurodegenerative diseased individuals. We demonstrate that AGS treatments of hMSC increased telomerase activity and hTERT levels in a time and dose dependent manner. Prolonged treatments with the compounds increased the average telomeres length, without altering population doublings (PD) or inducing chromosomal aberrations. AGS treatments of hMSC protected the cells from apoptosis and DNA damages induced by H2O2, and from the toxicity induced by long term exposure to DMSO. These AGS effects were shown to be mediated by telomerase since they were not observed when TERT was depleted from hMSC or in mouse embryonic stem cells derived from TERT knockout mice. Furthermore, AGS compounds did not alter the functionality of hMSC as examined by their ability to differentiate into various lineages in the presence of the compounds. These results suggest that pharmaceutical increase of telomerase may confer a beneficial therapeutic advantage in regenerative medicine when hMSC therapy is applied.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.2174/1566524011313060013
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Tichon, A., Eitan, E., Kurkalli, B.G., Braiman, A., Gazit, A., Slavin, S., Beith-Yannai, E., &amp; Priel, E. (2013). Oxidative Stress Protection by Novel Telomerase Activators in Mesenchymal Stem Cells Derived from Healthy and Diseased Individuals. <em>Current Molecular Medicine</em>. https://doi.org/10.2174/1566524011313060013
Vancouver
Tichon A, Eitan E, Kurkalli BG, Braiman A, Gazit A, Slavin S, et al. Oxidative Stress Protection by Novel Telomerase Activators in Mesenchymal Stem Cells Derived from Healthy and Diseased Individuals. Current Molecular Medicine. 2013. doi:10.2174/1566524011313060013.
BibTeX
@article{ailon2013Oxidat, title = {Oxidative Stress Protection by Novel Telomerase Activators in Mesenchymal Stem Cells Derived from Healthy and Diseased Individuals}, author = {Ailon Tichon and Erez Eitan and Basan Gowda Kurkalli and Alex Braiman and Aviv Gazit and Shimon Slavin and E. Beith-Yannai and Elad Priel}, journal = {Current Molecular Medicine}, year = {2013}, doi = {10.2174/1566524011313060013}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings